FDA's Approval of the First Biosimilar to Bevacizumab - Casak, S. J., Lemery, S. J., Chung, J., Fuchs, C., Schrieber, S. J., Chow, E. C. Y., Yuan, W., Rodriguez, L., Gwise, T., Rowzee, A., Lim, S., Keegan, P., McKee, A. E., Pazdur, R. (The American Association for Cancer Research (AACR), 2018)
6332633